Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.23.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Segment Reporting Information [Line Items]    
Revenues $ 0 $ 0
Gross profit 0 0
Depreciation and amortization 364 0
Total Interest expense, net (475) 2
Total Net income before income taxes (889) 2,619
Discontinued Operations    
Segment Reporting Information [Line Items]    
Revenues 3,795 9,324
Gross profit (197) 1,853
Operating loss 14,158 (410)
Depreciation and amortization 96 133
Total Interest expense, net (181) (190)
Total Net income before income taxes 13,976 (1,405)
Biotechnology    
Segment Reporting Information [Line Items]    
Revenues 0 0
Gross profit 0 0
Operating loss (1,099) (681)
Depreciation and amortization 364 0
Total Interest expense, net 475 (2)
Total Net income before income taxes (867) 2,619
Business Segment    
Segment Reporting Information [Line Items]    
Revenues 3,795 9,324
Gross profit (197) 1,853
Operating loss (13,059) (1,091)
Depreciation and amortization 460 133
Total Interest expense, net 294 (192)
Total Net income before income taxes $ 13,109 $ 1,214